Ireland
--:--IST
Latest
PulseAI of Belfast Says FDA Cleared Its Wearable ECG AI Airmid Éireann 1.6 Adds India and China Trials, Swiss Prices Irish Cancer Trial Enrolment at 2.9%, Under Half 6% Target FDA Accelerated Approval for J&J's Head and Neck Cancer Drug Korea Misses 2026 Biosimilar Approvals, Bets on Keytruda ArrayPatch Closes €3.2m Seed for GLP-1 Microneedle Patch PulseAI of Belfast Says FDA Cleared Its Wearable ECG AI Airmid Éireann 1.6 Adds India and China Trials, Swiss Prices Irish Cancer Trial Enrolment at 2.9%, Under Half 6% Target FDA Accelerated Approval for J&J's Head and Neck Cancer Drug Korea Misses 2026 Biosimilar Approvals, Bets on Keytruda ArrayPatch Closes €3.2m Seed for GLP-1 Microneedle Patch
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Changsha
Clinical trial register · China

Clinical Trials in Changsha, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19187 matching records held by the registry are in this view. Synced 09 Nov 2026, 03:17 UTC
19187
Studies in scope
all four open statuses
11790
Recruiting now
open to new participants
2028
Lead sponsors
across recruiting studies
Top sites
Changsha 48 Guangzhou 3 Hunan 1 Chang’an 1 Cili 1
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca139 Xiangya Hospital of Central South University48 Second Xiangya Hospital of Central South University37 Eli Lilly and Company37 Janssen Research & Development, LLC31 Clear sponsor filter
Site location
Changsha48 Guangzhou3 Hunan1 Chang’an1 Cili1
All 17 locations
Target enrolment
to

Trials with a site in Changsha

48 of 19187 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Xiangya Hospital of Central South University
Not applicable
15,400
Changsha
2026-11-30
Not yet open
Xiangya Hospital of Central South University
Phase 1
20
Changsha
2026-09-01
Not yet open
Xiangya Hospital of Central South University
Not applicable
64
Changsha
2026-08-01
Not yet open
EEG Changes and Cognitive Profiles in Sepsis Patients With Different Inflammatory Phenotypes
NCT07760415Sepsis, Sepsis Associated Encephalopathy, Sepsis and Septic Shock, Sepsis at Intensive Care Unit
Xiangya Hospital of Central South University
Observational
78
Changsha
2026-08-01
Not yet open
Xiangya Hospital of Central South University
Observational
120
Changsha
2026-07
Not yet open
Impact of Radiotherapy-Immunotherapy Timing in NSCLC Brain Metastases
NCT07638709Non Small Cell Lung, Brain Metastasases
Xiangya Hospital of Central South University
Observational
150
Changsha
2026-06-05
Not yet open
Xiangya Hospital of Central South University
Not applicable
90
Changsha
2026-06
Recruiting
Multicenter Prospective Study on MRI AI Model for Midline Glioma Subtyping and Prognosis:
NCT07608003Gliomas Harboring IDH1 and/or IDH2 Mutations, Glioma Glioblastoma Multiforme, Glioma of Brainstem, Glioma, Diffuse Midline, H3K27M-mutant
Xiangya Hospital of Central South University
Observational
500
Changsha
2026-05-10
Active, closed
RET-Targeted Molecular Imaging Probes in Prostate Cancer
NCT07886138Prostate Adenocarcinoma With Focal Neuroendocrine Differentiation, Prostate Cancer
Xiangya Hospital of Central South University
Early Phase 1
50
Changsha
2026-04-03
Recruiting
Xiangya Hospital of Central South University
Phase 4
152
Guangzhou, Changsha
2026-02-24
Recruiting
Xiangya Hospital of Central South University
Phase 4
1,092
Changsha
2026-02-02
Recruiting
Xiangya Hospital of Central South University
Phase 3
1,062
Changsha, Chang’an, Cili, Guankou, Huayuan, Lanshan, Leiyang, Pingjiang
2026-02-01
By invitation
Xiangya Hospital of Central South University
Observational
3,000
Changsha
2026-01-08
Recruiting
Xiangya Hospital of Central South University
Not applicable
104
Changsha
2025-12-24
Recruiting
Neuroprotection Bundles For Comatose Survivors Following Cardiac Arrest
NCT06992843Cardiac Arrest, Post-cardiac Arrest Care
Xiangya Hospital of Central South University
Not applicable
1,008
Changsha
2025-10-22
Active, closed
Microfocused Ultrasound for Facial Pigmentary Diseases and Rosacea
NCT07667972Melasma, Rosacea, Periorbital Hyperpigmentation, Melanosis
Xiangya Hospital of Central South University
Not applicable
200
Changsha
2025-10-01
Not yet open
Xiangya Hospital of Central South University
Phase 4
606
Changsha
2025-08
By invitation
Xiangya Hospital of Central South University
Phase 1
20
Changsha
2025-07-10
Recruiting
Xiangya Cardiopulmonary Health and Disease Cohort
NCT06972784Respiratory Function Tests，Heart Function Tests, Cardiopulmonary Function
Xiangya Hospital of Central South University
Observational
30,000
Changsha
2025-06-01
Recruiting
Xiangya Hospital of Central South University
Observational
900
Changsha
2025-05-20
Recruiting
A Vision-Language Foundation Model for Brain Disease Diagnosis From Multimodal Data
NCT07126821Brain (Nervous System) Cancers, Brain Arterial Disease, Neuro-Degenerative Disease, Brain Tumors
Xiangya Hospital of Central South University
Observational
100,000
Changsha
2025-05-15
Not yet open
Xiangya Hospital of Central South University
Phase 1/2
10
Changsha
2025-03-12
Recruiting
Xiangya Hospital of Central South University
Observational
1,000
Changsha
2025-03-11
Recruiting
Sleep Disordered Breathing and Multimorbidity: The Xiangya SDB Cohort Study
NCT06755840Sleep Disordered Breathing (SDB), Sleep Apnea, Cardiometabolic Diseases, Multimorbidity
Xiangya Hospital of Central South University
Observational
15,000
Changsha
2025-01-15
Recruiting
Xiangya Hospital of Central South University
Observational
240
Changsha
2025-01-01
Recruiting
Xiangya Hospital of Central South University
Observational
256
Changsha
2024-12-01
Recruiting
L-arginine for Knee Osteoarthritis Patients
NCT06054633Osteoarthritis, Knee
Xiangya Hospital of Central South University
Not applicable
340
Changsha
2024-03-20
Recruiting
Xiangya Hospital of Central South University
Observational
12,000
Changsha
2024-02-01
Recruiting
Personalized Anticoagulant Therapy for Pulmonary Thromboembolism
NCT06341231Pulmonary Thromboembolisms, Anticoagulants; Increased
Xiangya Hospital of Central South University
Observational
4,700
Changsha
2024-02-01
Recruiting
Development and Validation of a Prognostic Model for Neurocritical Patients Using Multimodal Brain Monitoring
NCT07115459Acute Brain Injury Coma, Neurocritical Care, Cerebral Infarction, Intracranial Hemorrhages
Xiangya Hospital of Central South University
Observational
200
Changsha
2024-01-08
Recruiting
Xiangya Hospital of Central South University
Observational
64
Changsha
2023-10-30
Active, closed
Xiangya Hospital of Central South University
Not applicable
250
Changsha
2023-06-01
Recruiting
Xiangya Hospital of Central South University
Not applicable
258
Changsha
2023-02-01
Recruiting
Xiangya Hospital of Central South University
Observational
200
Changsha
2022-04-30
Recruiting
Observational Study About Patients Diagnosed With NAFLD
NCT05625750Nonalcoholic Fatty Liver Disease
Xiangya Hospital of Central South University
Observational
500
Changsha
2022-04-27
Recruiting
Multicenter Cohort Study of AAV in Hunan of China
NCT05315141ANCA Associated Vasculitis
Xiangya Hospital of Central South University
Observational
500
Changsha
2022-03-16
Active, closed
Xiangya Hospital of Central South University
Observational
200
Changsha
2022-01-01
Recruiting
Xiangya Hospital of Central South University
Observational
360
Changsha
2021-12-01
Recruiting
Chinese DENOVO PD Registry
NCT05767151Parkinson Disease
Xiangya Hospital of Central South University
Observational
300
Changsha
2021-01-01
Active, closed
Clinical Study of Neoadjuvant Chemotherapy and Immunotherapy Combined With Probiotics in Patients With Resectable NSCLC
NCT04699721Non-small Cell Lung Cancer Stage II, Non-small Cell Lung Cancer Stage ⅢA, Non-small Cell Lung Cancer Stage IIIB
DrugNivolumab
Xiangya Hospital of Central South University
Phase 2
65
Changsha
2020-09-02
Active, closed
Xiangya Hospital of Central South University
Observational
100
Changsha
2020-07-01
Recruiting
Chinese ET Registry (CETR)
NCT04198246Essential Tremor
Xiangya Hospital of Central South University
Observational
1,000
Changsha
2019-01-01
Recruiting
Chinese PD-SNCA Registry
NCT03523052Parkinson Disease
Xiangya Hospital of Central South University
Observational
3,000
Changsha
2017-02-01
Recruiting
Chinese EOPD Registry
NCT03508960Parkinson Disease
Xiangya Hospital of Central South University
Observational
3,000
Changsha
2017-02-01
Recruiting
Chinese PD-GBA Registry
NCT03523065Parkinson Disease
Xiangya Hospital of Central South University
Observational
500
Changsha
2017-02-01
Recruiting
Chinese FPD Registry
NCT03508986Parkinson Disease
Xiangya Hospital of Central South University
Observational
1,500
Changsha
2017-02-01
Recruiting
Chinese PD-LRRK2 Registry
NCT03523104Parkinson Disease
Xiangya Hospital of Central South University
Observational
1,000
Changsha
2017-02-01
Active, closed
Xiangya Hospital of Central South University
Observational
4,080
Changsha
2015-11-17
Rows per page Showing 1–48 of 48
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 9 November 2026. https://priyalifescience.com/clinical-trials-china/city/changsha

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,187 studies in total at the last sync on 09 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 48 of those studies with a site in Changsha that also match the filters currently applied.

How many clinical trials are recruiting in Changsha?

30 of the 48 studies on this page are recruiting new participants as of the 09 Nov 2026, 03:17 UTC sync. A further 9 have not yet opened recruitment, 7 are active but closed to new participants, and 2 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Changsha), 48 studies
PhaseStudiesRecruitingShare
Observational302362.5%
Not applicable9418.8%
Phase 4326.3%
Phase 1204.2%
Early Phase 1102.1%
Phase 1/2102.1%
Phase 2102.1%
Phase 3112.1%

Most active sponsors

Lead sponsors with the most studies (Changsha)
Lead sponsorStudiesRecruiting
Xiangya Hospital of Central South University4830
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.